Prostate Cancer - Results from #80

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol). April 27, 2022

Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. April 27, 2022

Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer. April 26, 2022

Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia. April 26, 2022

Artificial intelligence supporting cancer patients across Europe-The ASCAPE project. April 26, 2022

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216). April 26, 2022

Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation. April 26, 2022

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy. April 25, 2022

Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer. April 25, 2022

Effect of Clinical Parameters on Risk of Death from Cancer after Radical Prostatectomy in Men with Localized and Locally Advanced Prostate Cancer. April 25, 2022

Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups. April 25, 2022

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. April 25, 2022

Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy. April 22, 2022

Role of 68Ga and 18F PSMA PET/CT and PET/MRI in biochemical recurrence of prostate cancer: a systematic review of prospective studies. April 22, 2022

A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study. April 22, 2022

Decisional Conflict is Associated with Treatment Modality and not Disease Knowledge in South African Men with Prostate Cancer: Baseline Results from a Longitudinal Prospective Observational Study. April 22, 2022

The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis. April 22, 2022

Androgen Deprivation and Sleep Disturbance: A Mixed Methods Pilot Study of Remote Assessment and Intervention. April 21, 2022

Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT). April 21, 2022

Prostate MRI percentage tumor involvement or "PI-RADS percent" as a predictor of adverse surgical pathology. April 21, 2022

Page 5 of 1222

email news signup